STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

So what does this mean for the future of biotech? Some investors and entrepreneurs are focused further downstream, finding very late-stage and even revenue-stage products. Some have shifted to ...

Moderna, a biotech giant that gained prominence during the COVID-19 pandemic, has revolutionized the biotechnology domain.

Wilmington Trust, the wealth management arm of M&T Bank, announced it has hired Karen… Shawmut Design and Construction, a $1.6 billion national construction management firm, celebrated the ...

does not mean that new drugs will emerge like Excalibur from a lake of data. People sometimes forget that drug R&D, whether it be in biotech or pharma or even academia, is an experimental science.

Biotech stocks jumped early Wednesday on hopes for more innovation and dealmaking after Donald Trump clinched his second presidency.

Glassdoor, Payscale, or more specifically BioPharmGuy (to look through a large variety of job offers similar to yours) are ...

While some analysts say Donald Trump is a wild card when it comes to drug pricing, many argue his presidency would be more ...

In the rapidly advancing field of biotechnology, precise analysis and accurate measurement are critical for research and ...

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices. Trum ...